Order Article Reprints

Kaddouri Y, Bouchal B, Abrigach F, El Kodadi M, Bellaoui M, Elkamhawy A, Touzani R, Abdellattif MH. New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties. Pharmaceuticals. 2022; 15(7):803. https://doi.org/10.3390/ph15070803

Kaddouri, Yassine, Btissam Bouchal, Farid Abrigach, Mohamed El Kodadi, Mohammed Bellaoui, Ahmed Elkamhawy, Rachid Touzani, and Magda H. Abdellattif. 2022. "New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties" Pharmaceuticals 15, no. 7: 803. https://doi.org/10.3390/ph15070803

Kaddouri, Y., Bouchal, B., Abrigach, F., El Kodadi, M., Bellaoui, M., Elkamhawy, A., Touzani, R., & Abdellattif, M. H. (2022). New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties. Pharmaceuticals, 15(7), 803. https://doi.org/10.3390/ph15070803